This will be very interesting and is going on right now.
Homeopathic Product Regulation: Evaluating FDA’s Regulatory Framework After a Quarter-Century
The Food and Drug Administration (FDA) is announcing a public hearing to obtain information and comments from stakeholders about the current use of human drug and biological products labeled as homeopathic, as well as the Agency’s regulatory framework for such products. These products include prescription drugs and biological products labeled as homeopathic and over-the-counter (OTC) drugs labeled as homeopathic. FDA is seeking participants for the public hearing and written comments from all interested parties, including, but not limited to, consumers, patients, caregivers, health care professionals, patient groups, and industry. FDA is seeking input on a number of specific questions, but is interested in any other pertinent information participants would like to share.
Date
April 20-21, 2015
Time
9:00 am to 4:00 pm
Location
FDA White Oak Campus
10903 New Hampshire Avenue
Bldg. 31, Room 1503A (Great Room)
Silver Spring, Maryland 20993
Public Participation
Registration and Requests for Oral Presentations: Registration for in-person attendance and oral presentations closed at 5 p.m. EST on April 13, 2015.
Streaming Webcast of the Public Hearing: FDA will provide a live Webcast of the hearing. Information about how you can access a live Webcast will be located at Homeopathic Product Regulation.
Federal Register Notice
Submit Comments to the Public Docket
White Oak Campus Visitor Information
Agenda
The agenda (PDF - 105KB) is now available.
Contact Information
CDERhomeopathicproduct@fda.hhs.gov Homeopathic Product Regulation: Evaluating FDA?s Regulatory Framework After a Quarter-Century